As of Wednesday close, Edwards Lifesciences Corporation’s (NYSE:EW) stock was down -$0.01, moving down -0.01 percent to $77.82. The average number of shares traded per day over the past five days has been 2,645,580 shares. 4 times new highs have been achieved over the past 5 days, with a $1.92 gain in that time frame. In the last twenty days, the average volume was 3,307,255, while in the previous 50 days, it was 3,134,476.
Since last month, EW stock retreated -5.16%. Shares of the company fell to $74.90 on 08/25/23, the lowest level in the past month. A 52-week high of $98.35 was reached on 06/30/23 after having rallying from a 52-week low of $67.13. Since the beginning of this year, EW’s stock price has risen by 4.30% or $3.21, and marked a new high 20 times. However, the stock has declined by -20.87% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
EW stock investors should be aware that Edwards Lifesciences Corporation (EW) stock had its last reported insider trading activity 2 days ago on Aug 29. Chopra Daveen, the CVP, TMTT of the company, disposed of 1,500 shares for $76.69 on Aug 29. It resulted in a $115,040 divestment by the insider. Wood Larry L sold 6,421 shares at an average price of $79.30 on Aug 14. The insider now owns 213,794 shares following the transaction. On Aug 14, CVP,Strategy/Corp Development BOBO DONALD E JR sold 4,500 shares at $79.30 apiece. The transaction was valued at $356,850.
Valuation Metrics
Right now, Edwards Lifesciences Corporation (EW) has a P/E ratio of about 34.48. The stock’s beta is 1.03. Besides these, the trailing price-to-sales (P/S) ratio of 8.24, the price-to-book (PB) ratio of 7.40, and the price-to-cash flow ratio of 68.31 may also be considered.
Financial Health
In the three months ended June 29, Edwards Lifesciences Corporation’s quick ratio stood at 2.30, while its current ratio was 3.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.09, and the total debt-to-equity ratio was 0.09. On the profitability front, the trailing twelve-month gross margin is 79.10% percent. In the year ended June 29, EBITDA margin amounted to 34.73%, whereas operating margins totaled 27.70%. Based on annual data, EW earned $4.3 billion in gross profit and brought in $5.38 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 23.50%. Return on equity (ROE) for the past 12 months was 22.80%.
In Edwards Lifesciences Corporation’s quarter-end financial report for June 29, it reported total debt of $596.7 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. EW’s revenue rose 10.21% to $1.46 billion during the quarter, while net income inched up to $1.53 billion. While analysts expected Edwards Lifesciences Corporation to report $0.65 quarterly earnings, the actual figure was $0.66 per share, beating the consensus estimate by 1.50%. During the quarter, the company generated $363.3 million in EBITDA. The liabilities of Edwards Lifesciences Corporation were 2.56 billion at the end of its most recent quarter ended June 29, and its total debt was $684.5 million. The value of shareholders’ equity is $607.92 million.
Technical Picture
This quick technical analysis looks at Edwards Lifesciences Corporation’s (EW) price momentum. With a historical volatility rate of 16.28%, the RSI 9-day stood at 47.08% on 30 August.
With respect to its five-day moving average, the current Edwards Lifesciences Corporation price is up by +2.53% percent or $1.92. At present, EW shares trade -3.18% below its 20-day simple moving average and -7.22% percent below its 100-day simple moving average. However, the stock is currently trading approximately -15.33% below its SMA50 and +7.26% above its SMA200.
Stochastic coefficient K was 39.43% and Stochastic coefficient D was 27.80%, while ATR was 1.48. Given the Stochastic reading of 49.49% for the 14-day period, the RSI (14) reading has been calculated as 40.43%. As of today, the MACD Oscillator reading stands at 0.82, while the 14-day reading stands at -0.13.
